View Older Stories

Apr 3, 2023 08:00AM Esperion to Participate in Needham 22nd Annual Virtual Healthcare Conference

Apr 28, 2022 04:00PM Esperion Therapeutics (ESPR) Appoints Stephen Rocamboli to its Board

Apr 28, 2022 04:00PM Esperion Announces the Appointment of Stephen Rocamboli to its Board of Directors

Apr 28, 2022 04:00PM Esperion Announces the Appointment of Stephen Rocamboli to its Board of Directors

Mar 29, 2022 08:00AM Esperion to Participate in Upcoming 21st Annual Needham Virtual Healthcare Conference

Mar 29, 2022 08:00AM Esperion to Participate in Upcoming 21st Annual Needham Virtual Healthcare Conference

Feb 22, 2022 12:03PM Esperion Therapeutics (ESPR) Reiterated at Buy by Needham & Company, Expect Nexletol/Nexlizet to Deliver Important Sales Growth, but Focus Remains on CLEAR Trial Results

Dec 8, 2021 12:12PM Esperion Therapeutics (ESPR) PT Lowered to $12 at Needham & Company, Keeps 'Buy' as Financing Extends Runway Into 2023

Aug 3, 2021 11:31AM Esperion Therapeutics (ESPR) PT Lowered to $114 at Needham & Company

Apr 6, 2021 08:00AM Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference

Apr 6, 2021 08:00AM Esperion to Participate in Fireside Chat at the 20th Annual Needham Virtual Healthcare Conference

Feb 24, 2021 07:14AM Esperion Therapeutics (ESPR) PT Lowered to $134 at Needham & Company

Apr 9, 2020 08:00AM Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare Conference

Apr 9, 2020 08:00AM Esperion to Participate in Fireside Chat at the 19th Annual Needham Virtual Healthcare Conference

Feb 24, 2020 11:28AM Esperion Therapeutics (ESPR) PT Raised to $158 at Needham & Company

Apr 2, 2019 04:30PM Esperion to Present at the Needham & Company 18th Annual Healthcare Conference

Apr 2, 2019 04:30PM Esperion to Present at the Needham & Company 18th Annual Healthcare Conference

Jul 11, 2018 07:16AM Thoughts From Esperion Therapeutics (ESPR) Analyst Day - Needham

May 2, 2018 01:06PM UPDATE: Needham Remains Confident in Efficacy and Safety Profile of Esperion Therapeutics' (ESPR) Bempedoic Acid

May 2, 2018 08:39AM Buyer of Esperion Therapeutics (ESPR) on Weakness - Needham & Company

Mar 27, 2018 09:01AM Pre-Open Movers 03/27: (ATRS) (PETX) (RHT) Higher; (LFIN) (GERN) (OSTK) Lower (more...)

Mar 7, 2018 12:22PM Needham Remains Positive on Esperion Therapeutics (ESPR)

Feb 21, 2018 07:19AM Esperion Therapeutics (ESPR) PT Raised to $94 at Needham & Company

Dec 14, 2017 09:22AM Pre-Open Movers 12/14: (TEVA) (BAND) (NSDS) Higher; (PIR) (TNTR) (ABM) Lower (more...)

Dec 14, 2017 07:05AM Needham & Company Upgrades Esperion Therapeutics (ESPR) to Strong Buy, Top Pick

Aug 10, 2017 05:53AM Esperion Therapeutics (ESPR) Prices 3.1M Share Common Offering at $49/Sh

Aug 9, 2017 09:20PM Esperion Prices Public Offering of Common Stock

Aug 8, 2017 11:55AM UPDATE: Esperion Therapeutics (ESPR) PT Raised to $72 at Needham & Company

Mar 28, 2017 04:30PM Esperion to Participate in Fireside Chat at the 16th Annual Needham Healthcare Conference

Mar 20, 2017 01:00PM Esperion Therapeutics (ESPR) PT Raised to $58 at Needham & Company

Mar 17, 2017 11:19AM Esperion (ESPR) Sell-Off on Amgen Data 'Counter-Intuitive'- Needham & Company

Feb 3, 2017 01:09PM Esperion Therapeutics (ESPR) 'Significantly Undervalued' Despite Move - Needham & Company

Jan 10, 2017 06:22AM Esperion Therapeutics (ESPR): Pivotal Bempedoic Acid Program Fully Underway - Needham

Oct 13, 2016 12:05PM Streetinsider.com's Hot Lunchtime Reads 10/13: (TWTR) (ESPR) (SSYS) (APTO)

Jun 29, 2016 02:27PM Esperion Therapeutics (ESPR) PT Cut to $25 at Needham & Company After Update, Maintains 'Buy'

Nov 11, 2015 07:43AM Needham & Company Positive on Esperion (ESPR) Following Presentation of New ETC-1002 Data at AHA

Sep 30, 2015 09:32AM Pre-Open Stock Movers 09/30: (EZCH) (RENT) (WDC) Higher; (CUDA) (PLNT) (VRNT) Lower (more...)

Sep 30, 2015 06:51AM Esperion Therapeutics (ESPR) 'Highly Oversold', Needham & Company Says

Aug 19, 2015 10:26AM Notable Analyst Rating Changes 8/19: (SJM) (WTW) (GOOG) Upgraded; (ESPR) (AFL) (MEOH) Downgraded

Aug 19, 2015 09:30AM Pre-Open Stock Movers 08/19: (HILL) (CRBP) (ACI) (TGT) Higher; (TEDU) (CSIQ) (MNOV) Lower (more...)

Aug 19, 2015 06:33AM Needham & Company Downgrades Esperion Therapeutics (ESPR) to Buy; CVOT Not Required, But Initial Label Will Be Narrower

Aug 10, 2015 09:33AM Pre-Open Stock Movers 08/10: (AQXP) (VLTC) (INO) (PCP) Higher; (SYN) (JD) (FCX) Lower (more...)

Aug 10, 2015 07:08AM Needham & Company Upgrades Esperion Therapeutics (ESPR) to Strong Buy; Shares Will Rebound

Jul 28, 2015 12:14PM Streetinsider.com's Hot Lunchtime Reads 7/28: (TWTR) (MU) (MGM) (ESPR)

Jul 28, 2015 11:26AM Needham & Company Pleased with Esperion (ESPR) LDL Data for ETC-1002, Recommends Buying on Weakness

Jun 10, 2015 08:15AM Alirocumab AdComm Net Positive for Esperion Therapeutics (ESPR) ETC-1002, Needham & Company Says

May 8, 2015 07:46AM Esperion Therapeutics (ESPR) PT Raised to $130 at Needham & Company

Apr 7, 2015 04:30PM Esperion Therapeutics to Present at 14th Annual Needham Healthcare Conference

Mar 24, 2015 04:05PM Esperion Therapeutics Announces Closing of Follow-On Public Offering and Exercise in Full of Underwriters' Option to Purchase Additional Shares of Common Stock

Mar 19, 2015 06:47AM Esperion Therapeutics (ESPR) Prices 1.75M Common Offering at $100/Share

View Older Stories